Mesoblast Limited (MESO)
NASDAQ·Healthcare·Biotechnology
$15.21
-0.78%
Mkt Cap $1.99B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $53.06M | $51.34M | -3.25% | -$0.24 | -$0.31 | -31.22% | — | — |
| Q3 2025 Sep 3, 2025 | $30.68M | $7.02M | -77.11% | -$0.37 | -$0.21 | +42.98% | — | — |
| Q2 2025 Apr 30, 2025 | $7.48M | $7.02M | -6.15% | — | -$0.21 | — | — | — |
| Q1 2025 Feb 26, 2025 | $7.48M | $1.58M | -78.91% | -$0.25 | -$0.21 | +16.08% | — | — |
| Q4 2024 Oct 30, 2024 | $3.47M | $1.58M | -54.52% | -$0.31 | -$0.28 | +9.68% | — | — |
| Q3 2024 Jul 4, 2024 | $3.81M | $1.26M | -67.02% | -$0.35 | -$0.26 | +25.71% | — | — |
| Q1 2024 Mar 25, 2024 | $3.87M | $1.69M | -56.22% | -$0.40 | -$0.34 | +15.00% | — | — |
| Q4 2023 Dec 26, 2023 | $5.60M | $1.69M | -69.75% | -$0.25 | -$0.12 | +51.32% | — | — |
| Q3 2023 Aug 30, 2023 | $2.38M | $2.14M | -10.25% | -$0.28 | -$0.28 | -1.13% | — | — |
| Q2 2023 May 25, 2023 | $2.14M | $1.94M | -9.38% | -$0.31 | -$0.26 | +17.40% | — | — |
| Q1 2023 Feb 27, 2023 | $2.10M | $1.98M | -5.71% | -$0.27 | -$0.34 | -28.07% | — | — |
| Q4 2022 Nov 22, 2022 | $3.47M | $1.44M | -58.38% | -$0.31 | -$0.24 | +22.51% | — | — |
| Q3 2022 Aug 30, 2022 | $7.59M | $2.22M | -70.71% | -$0.19 | -$0.34 | -74.92% | — | — |
| Q2 2022 May 31, 2022 | $2.10M | $2.01M | -4.24% | -$0.26 | -$0.32 | -25.00% | — | — |
| Q1 2022 Feb 24, 2022 | $3.50M | $2.38M | -31.94% | -$0.39 | -$0.40 | -3.74% | — | — |
| Q4 2021 Nov 23, 2021 | $2.46M | $3.59M | +46.10% | -$0.30 | -$0.34 | -13.33% | — | — |
| Q3 2021 Aug 31, 2021 | $1.87M | $2.00M | +6.72% | -$0.32 | -$0.34 | -6.25% | — | — |
| Q2 2021 Jun 2, 2021 | — | $1.91M | — | -$0.20 | -$0.44 | -120.00% | — | — |
| Q1 2021 Mar 2, 2021 | $1.71M | $2.24M | +31.02% | -$0.36 | -$0.44 | -22.22% | — | — |
| Q4 2020 Nov 19, 2020 | — | $1.29M | — | $0.16 | -$0.42 | -362.50% | — | — |